Rare diseases
Investigational molecules
Locations
Study of Pembrolizumab with Cisplatin or Carboplatin and Pemetrexed for Patients with Resectable Malignant Pleural Mesothelioma
ItalyStudy on the Safety of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy Who Completed a Previous Trial
BelgiumStudy on Atezolizumab and Resiquimod Sulfate with Radiotherapy for Patients with Advanced Solid Tumors
FranceStudy on Allergenic Extracts of Mites and Histamine Dihydrochloride for Allergy Patients
SpainStudy on the Safety and Effectiveness of BOOST Cells for Treating Severe Osteogenesis Imperfecta in Children Before and After Birth
The NetherlandsStudy of Fibrinogen Treatment for Bleeding in Patients with Blood Cancer and Low Platelet Count Who Do Not Respond to Platelet Transfusions
FranceStudy on Pembrolizumab and Olaparib for Patients with Resectable Soft Tissue Sarcoma
FranceTitle: Study of everolimus with hormone therapy in women with high-risk breast cancer (ER-positive, HER2-negative) who are disease-free after initial treatment
BelgiumStudy of Domvanalimab, Zimberelimab, and Chemotherapy for Patients with Advanced Esophageal or Gastric Cancer
FranceStudy on Vaginal Tamoxifen for Improving Sexual Function in Women with Breast Cancer Experiencing Vulvovaginal Atrophy Symptoms
SwedenStudy of regorafenib and nivolumab with radiotherapy for patients with stage II-III rectal cancer before surgery
BelgiumStudy on Abemaciclib and Endocrine Therapy for Patients with Advanced Hormone Receptor Positive HER2 Negative Breast Cancer
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
